The interplay between CKD, sudden cardiac death, and ventricular arrhythmias
Related Experiment Video
Updated: Apr 20, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
1Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC.
Insights
Patients with chronic kidney disease (CKD) have a higher risk of sudden cardiac death (SCD). This review explores CKD-specific factors, pathophysiology, and therapies for SCD in these patients.
Area of Science:
- Nephrology and Cardiology
- Cardiovascular Disease Research
- Clinical Medicine
Background:
- Chronic kidney disease (CKD) is linked to increased cardiovascular disease mortality.
- Sudden cardiac death (SCD) risk escalates with declining kidney function.
- Traditional coronary heart disease risk factors are less influential in CKD patients.
Purpose of the Study:
- To review current understanding of SCD epidemiology and pathophysiology in CKD.
- To examine the role of CKD-specific factors in SCD.
- To evaluate current pharmacologic and device-based therapies for SCD risk in CKD.
Main Methods:
- Literature review of recent data on SCD in CKD patients.
- Analysis of epidemiological trends and risk factors.
- Examination of pathophysiological mechanisms and therapeutic strategies.
Main Results:
- SCD risk is significantly elevated in CKD patients.
- CKD-specific factors, structural heart disease, and arrhythmias are key contributors to SCD.
- Traditional risk factors have a diminished role in SCD among CKD patients.
Conclusions:
- Understanding CKD-specific SCD mechanisms is crucial.
- Novel therapeutic approaches are needed for managing SCD risk in CKD.
- Further research is required to optimize pharmacologic and device-based therapies.
Abstract:
CKD patients face an increased risk of cardiovascular disease mortality, and the risk of sudden cardiac death (SCD) increases as kidney function declines. Risk factors for SCD are poorly understood and understudied among CKD patients. In the general population, coronary heart disease-associated risk factors are the most important determinants of SCD risk, but among CKD patients, there is evidence that these factors play a much smaller role. Complex relationships between CKD-specific risk factors, structural heart disease, and arrhythmic triggers contribute to the high risk of SCD and ventricular arrhythmias and modulate the effectiveness of available therapies. This review examines recent data on the epidemiology, pathophysiology, and mechanisms of SCD among CKD patients and examines current evidence regarding the use of pharmacologic and device-based therapies for management of SCD risk.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
06:46Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Acute Kidney Injury II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias